Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and SOLAR-2 Studies Compared to a Real-world Dataset
Authors
Charlton, M; Cheung, MCM; Manns, M; Sajed, N; Troke, PJF; Spellman, J; Copans, A; Arterburn, S; Brainard, DM; Irving, WLCollections
- Centre for Immunobiology [1121]